Hongbo Zou
Overview
Explore the profile of Hongbo Zou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
143
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Fu Y, Zou H, Wang P, Xu Y, Xie Q
Oncol Lett
. 2024 Dec;
29(2):87.
PMID: 39677411
Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality worldwide, necessitating new treatment approaches with minimal side effects. In the present study, the potential of Bergapten (5-methoxypsoralen),...
2.
Zou H, Yin Y, Xiong K, Luo X, Sun Z, Mao B, et al.
Technol Cancer Res Treat
. 2024 Oct;
23:15330338241282080.
PMID: 39360506
Background: Abnormal mitochondrial pyruvate carrier 1 (MPC1) expression plays a key role in tumor metabolic reprogramming and progression. Understanding its significance in non-small cell lung cancer (NSCLC) is crucial for...
3.
Que D, Zou H, Mao B, Zhang H, Liang W, Liu Q, et al.
Front Oncol
. 2022 Dec;
12:967675.
PMID: 36523965
Introduction: Traditional therapeutic approaches for the treatment of advanced non-small-cell lung cancer (NSCLC) are based on chemotherapy. However, the discovery and understanding of oncogenic driver alterations has led to the...
4.
Dong W, Chen W, Zou H, Shen Z, Yu D, Chen W, et al.
Oxid Med Cell Longev
. 2022 Dec;
2022:9159101.
PMID: 36466088
Sarcopenia, featured by the progressive loss of skeletal muscle function and mass, is associated with the impaired function of muscle stem cells (MuSCs) caused by increasing oxidative stress in senescent...
5.
Liu Z, Shen Z, Zhang P, Zhu G, Wang S, Liu Q, et al.
Heart Lung Circ
. 2022 Aug;
31(10):1408-1418.
PMID: 35961821
Background: As the proportion of elderly patients increases, higher incidence of malnutrition is found among patients with valvular heart disease. Sarcopaenia is one of the main manifestations of malnutrition. Studies...
6.
Xu C, Jin G, Wu H, Cui W, Wang Y, Manne R, et al.
J Clin Invest
. 2022 Mar;
132(5).
PMID: 35229723
Cancer stem-like cells (CSLCs) acquire enhanced immune checkpoint responses to evade immune cell killing and promote tumor progression. Here we showed that signal regulatory protein γ (SIRPγ) determined CSLC properties...
7.
Yan X, Shen Z, Yu D, Zhao C, Zou H, Ma B, et al.
Free Radic Biol Med
. 2021 Nov;
178:59-75.
PMID: 34823019
The progressive and generalized loss of skeletal muscle mass and function, also known as sarcopenia, underlies disability, increasing adverse outcomes and poor quality of life in older people. Exercise interventions...
8.
Dai D, Yin Y, Hu Y, Lu Y, Zou H, Lu G, et al.
Drug Deliv
. 2021 Jul;
28(1):1548-1561.
PMID: 34286631
Purpose: Tumor RNA vaccines can activate dendritic cells to generate systemic anti-tumor immune response. However, due to easily degraded of RNA, direct RNA vaccine is less effective. In this study,...
9.
Liu Y, Zou H, Xie Q, Zou L, Kong R, Mao B
Biomed Eng Online
. 2021 Jul;
20(1):67.
PMID: 34217312
Hepatocellular carcinoma (HCC) is currently the sixth most common malignancy and the second major cause of tumor-related deaths in the world. This study aimed to investigate the role of cleavage...
10.
Wu H, Wang T, Liu Y, Li X, Xu S, Wu C, et al.
J Exp Clin Cancer Res
. 2020 Dec;
39(1):274.
PMID: 33280610
Background: The identification of novel targets for recovering sorafenib resistance is pivotal for Hepatocellular carcinoma (HCC) patients. Mitophagy is the programmed degradation of mitochondria, and is likely involved in drug...